Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 7:07 pm Sale | 2023-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | BIOGEN INC. BIIB | 12,751,365 9.230% | -558,878 (-4.20%) | Filing History |
| 2024-02-08 10:11 am Purchase | 2023-12-29 | 13G | DENALI THERAPEUTICS INC DNLI | Wellington Management Group LLP | 7,274,717 5.260% | 7,274,717 (New Position) | Filing History |
| 2024-01-30 06:59 am Sale | 2023-12-29 | 13G | DENALI THERAPEUTICS INC DNLI | BAILLIE GIFFORD & CO | 14,260,724 10.320% | -858,750 (-5.68%) | Filing History |
| 2024-01-30 06:40 am Unchanged | 2023-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | Temasek Holdings (Private) Ltd | 6,895,992 4.900% | 0 (Unchanged) | Filing History |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 11,542,861 8.400% | 2,221,432 (+23.83%) | Filing History |
| 2023-03-30 06:14 am Purchase | 2023-03-23 | 13G | DENALI THERAPEUTICS INC DNLI | Temasek Holdings (Private) Ltd | 6,895,992 5.000% | 6,895,992 (New Position) | Filing History |
| 2023-02-13 4:14 pm Sale | 2022-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | BRATTON DOUGLAS K | 7,000,882 5.200% | -844,307 (-10.76%) | Filing History |
| 2023-02-09 11:16 am Purchase | 2022-12-30 | 13G | DENALI THERAPEUTICS INC DNLI | VANGUARD GROUP INC | 9,947,098 7.320% | 1,785,568 (+21.88%) | Filing History |
| 2023-02-09 08:14 am Sale | 2023-02-09 | 13G | DENALI THERAPEUTICS INC DNLI | FMR LLC | 5,854,035 4.310% | -737,998 (-11.20%) | Filing History |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 9,321,429 6.900% | 1,210,607 (+14.93%) | Filing History |
| 2023-01-20 10:05 am Purchase | 2022-12-30 | 13G | DENALI THERAPEUTICS INC DNLI | BAILLIE GIFFORD & CO | 15,119,474 11.130% | 63,093 (+0.42%) | Filing History |
| 2022-02-14 2:37 pm Sale | 2021-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | BRATTON DOUGLAS K | 7,845,189 6.400% | -4,503,595 (-36.47%) | Filing History |
| 2022-02-14 2:34 pm Sale | 2021-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | T. Rowe Price Associates, Inc. | 4,635,433 3.700% | -1,829,393 (-28.30%) | Filing History |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | VANGUARD GROUP INC | 8,161,530 6.680% | 236,473 (+2.98%) | Filing History |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | DENALI THERAPEUTICS INC DNLI | FMR LLC | 6,592,033 5.397% | 424,096 (+6.88%) | Filing History |
| 2022-02-08 3:04 pm Sale | 2021-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | ARCH Venture Fund VIII L.P. | 0 0.000% | -10,735,948 (Position Closed) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 8,110,822 6.600% | 1,734,744 (+27.21%) | Filing History |
| 2022-01-18 11:50 am Purchase | 2021-12-31 | 13G | DENALI THERAPEUTICS INC DNLI | BAILLIE GIFFORD & CO | 15,056,381 12.330% | 2,866,125 (+23.51%) | Filing History |